Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea-a prospective intervention study

What Was Tested

The paper reports a study of ANP (Atrial Natriuretic Peptide) and Adrenomedullin in the context of sleep apnea (obstructive), published as an observational study.

Obstructive sleep apnea (OSA) might lead to oxidative stress, inflammation and elevated circulating copeptin, proANP and proADM levels.

The researchers aimed to evaluate whether the levels of these prohormones are higher in patients with OSA and whether they might change under continuous positive airway pressure (CPAP) therapy, serving as potential proxies for the diagnosis and therapy-response in OSA.

Who Took Part

According to the abstract, 310 patients were involved.

The age groups tagged for this paper are adults, middle-aged adults and older adults, both men and women.

A total of 310 patients with suspicion of OSA were recruited.

All patients diagnosed with OSA underwent CPAP adaptation.

How the Study Was Run

Screening for OSA was performed using overnight pulse oximetry followed by polygraphy and a venous puncture in the morning.

A venous puncture was conducted in the night before CPAP and in the following morning.

In the acquired blood, copeptin, proANP and proADM levels were measured.

What Was Measured

Topics PubMed links to this paper include Adrenomedullin, Atrial Natriuretic Factor, Biomarkers, Continuous Positive Airway Pressure, Glycopeptides, Hypoxia and Longitudinal Studies.

The authors tagged it with the keywords CPAP, Copeptin, OSA, ProADM and ProAMP.

What This Means in Plain Language

This is an observational study of ANP (Atrial Natriuretic Peptide) and Adrenomedullin in 310 patients in people with sleep apnea (obstructive).

With several hundred people or more, it is a fairly large study for this kind of research.

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2021 (Respiratory research), a journal based in England.

More context: the ANP (Atrial Natriuretic Peptide) compound page and the Adrenomedullin compound page, Sleep apnea (obstructive) research.